Correlation Between Philip Morris and Abcellera Biologics

Can any of the company-specific risk be diversified away by investing in both Philip Morris and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Philip Morris and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Philip Morris International and Abcellera Biologics, you can compare the effects of market volatilities on Philip Morris and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Philip Morris with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Philip Morris and Abcellera Biologics.

Diversification Opportunities for Philip Morris and Abcellera Biologics

0.64

Correlation Coefficient

Philip Morris  Abcellera Biologics

Poor diversification

The 3 months correlation between Philip and Abcellera is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Philip Morris International and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Philip Morris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Philip Morris International are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Philip Morris i.e., Philip Morris and Abcellera Biologics go up and down completely randomly.

Pair Corralation between Philip Morris and Abcellera Biologics

Allowing for the 90-day total investment horizon Philip Morris International is expected to generate 0.33 times more return on investment than Abcellera Biologics. However, Philip Morris International is 3.0 times less risky than Abcellera Biologics. It trades about 0.06 of its potential returns per unit of risk. Abcellera Biologics is currently generating about -0.06 per unit of risk. If you would invest  9,468  in Philip Morris International on September 19, 2024 and sell it today you would earn a total of  3,126  from holding Philip Morris International or generate 33.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Philip Morris International  vs.  Abcellera Biologics

Philip Morris Intern

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Philip Morris International are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak primary indicators, Philip Morris may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Abcellera Biologics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Philip Morris and Abcellera Biologics

The main advantage of trading using opposite Philip Morris and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Philip Morris position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.

The idea behind Philip Morris International and Abcellera Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.